» Authors » Emerson Lucena da Silva

Emerson Lucena da Silva

Explore the profile of Emerson Lucena da Silva including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 133
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Noronha Souza P, Zelaya E, da Silva E, Brasil-Oliveira L, de Oliveira F, de Moraes M, et al.
Int J Biol Macromol . 2025 Jan; 299:140204. PMID: 39848367
Colorectal cancer (CRC) affects the population worldwide, occupying the first place in terms of death and incidence. Synthetic peptides (SPs) emerged as alternative molecules due to their activity and low...
2.
da Silva E, Mesquita F, Pinto L, Gomes B, de Oliveira E, Burbano R, et al.
Comput Biol Med . 2024 Nov; 184:109415. PMID: 39566281
Gastric cancer (GC) is a common cancer worldwide. Therefore, searching for effective treatments is essential, and drug repositioning can be a promising strategy to find new potential drugs for GC...
3.
Aranha E, Mendonca L, Almeida B, da Silva E, Mesquita F, Lima E, et al.
Toxicol In Vitro . 2024 Jun; 99:105883. PMID: 38936442
Melanoma is a type of tumor skin with high metastatic potential. Reconstructed human skin, development for pre-clinic assay, are make using primary human cells, but with same limitations. The aim...
4.
Mesquita F, Lima L, da Silva E, Noronha Souza P, de Moraes M, Burbano R, et al.
Curr Protein Pept Sci . 2024 Feb; 25(7):539-552. PMID: 38424421
Gastric adenocarcinoma is a complex disease with diverse genetic modifications, including Anaplastic Lymphoma Kinase (ALK) gene changes. The ALK gene is located on chromosome 2p23 and encodes a receptor tyrosine...
5.
Machado C, da Silva E, Ferreira W, DE Pinho Pessoa F, de Quadros A, Fantacini D, et al.
Cancers (Basel) . 2023 Dec; 15(23). PMID: 38067214
Detection of t(9;22), and consequent fusion, is still a marker of worse prognosis for acute lymphoblastic leukemia (ALL), with resistance to tyrosine-kinase inhibitor therapy being a major obstacle in the...
6.
Marinho A, da Silva E, Jullyanne de Sousa Portilho A, DE Oliveira L, Cintra Austregesilo Bezerra E, Dias Nogueira B, et al.
Toxicon . 2023 Dec; 238:107547. PMID: 38065258
Cancer is indisputably one of the leading causes of death worldwide. Snake venoms are a potential source of bioactive compounds, complex mixtures constituted mainly of proteins and peptides with several...
7.
da Silva E, Mesquita F, Aragao D, Jullyanne de Sousa Portilho A, Marinho A, DE Oliveira L, et al.
Toxicol Appl Pharmacol . 2023 Jul; 475:116630. PMID: 37473966
Gastric cancer (GC) is among the most-diagnosed and deadly malignancies worldwide. Deregulation in cellular bioenergetics is a hallmark of cancer. Based on the importance of metabolic reprogramming for the development...
8.
Mesquita F, Noronha Souza P, Aragao D, Diogenes E, da Silva E, Amaral J, et al.
Future Virol . 2023 Apr; PMID: 37064326
This study aimed to analyze the phylogenetic relationships between the ACE2 of humans and other animals and investigate the potential interaction between SARS-CoV-2 RBD and ACE2 of different species. The...
9.
da Silva E, Mesquita F, Ramos I, Gomes C, Moreira C, Ferreira V, et al.
Toxicol Appl Pharmacol . 2022 Oct; 456:116256. PMID: 36208702
Colorectal cancer (CRC) is estimated as the third most incident cancer and second in mortality worldwide. Moreover, CRC metastasis reduces patients' survival rates. Thus, the study and identification of new...
10.
Mesquita F, Noronha Souza P, da Silva E, Lima L, DE Oliveira L, Moreira-Nunes C, et al.
Pharmaceutics . 2022 Sep; 14(9). PMID: 36145589
Despite advances in cancer chemotherapy, gastric cancer (GC) continues to have high recurrence rates and poor prognosis with limited treatment options. Understanding the etiology of GC and developing more effective,...